Results 71 to 80 of about 69,031,262 (351)

COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?

Infectious Disease Reports, 2021
SARS-CoV-2 (COVID-19) has been changing the world since December 2019. A comprehensive search into many COVID-19 treatment guidelines was conducted and reported in this article.
F. Jirjees, A. K. Saad, Z. AlHano, T. Hatahet, Hala Al Obaidi, Yahya H. Dallal Bashi   +5 more
semanticscholar   +1 more source

Treatment for COVID-19: An overview

European Journal of Pharmacology, 2020
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a characteristic hyperinflammatory response, vascular damage, microangiopathy, angiogenesis and widespread thrombosis.
Stasi, Cristina, Fallani, Silvia, Voller, Fabio, Silvestri, Caterina   +3 more
openaire   +2 more sources

Interferon-α2b treatment for COVID-19 [PDF]

Frontiers in Immunology, 2020
Abstract Background The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon-α2b in a cohort of confirmed COVID-19 cases in Wuhan, China.
Qiong Zhou, Virginia Chen, Casey P. Shannon, Xiao-Shan Wei, Xuan Xiang, Xu Wang, Zi-Hao Wang, Scott J. Tebbutt, Scott J. Tebbutt, Tobias R. Kollmann, Eleanor N. Fish   +10 more
openaire   +3 more sources

Features of the new coronavirus COVID-19 infection in identical twins

Инфекция и иммунитет, 2022
The problem of the clinical course and principles of treatment for the new coronavirus infection COVID-19 remains the most debated issue. At the same time, reliable prognostic criteria that determine characteristics of the disease course and outcome have
S. M. Yudina, V. V. Kiseleva, Tatyana S. Rusanova, I. A. Ivanova   +3 more
doaj   +1 more source

Detection, prevention and treatment of COVID‐19 and opportunities for nanobiotechnology

View, 2022
Since the outbreak of COVID‐19, the number of confirmed cases and deaths has increased globally at a dramatic speed. In view of the serious health threat to humans, this review discusses the state‐of‐the‐art studies about fighting this disease.
Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao   +3 more
doaj   +1 more source

A follow-up study to evaluate psychological impact among patients admitted for COVID-19 treatment to a tertiary care hospital

Telangana Journal of Psychiatry, 2021
Introduction: Coronavirus disease 19 (COVID-19) is a pandemic caused by a novel virus. It is associated with higher infectivity and mortality, which has led to a rise in psychological problems.
Abdul Salaam Mohammed, Raj Kiran Donthu, Sankar Reddy Tamanampudi Pratap, Ramya Krishna Kurma   +3 more
doaj   +1 more source

Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?

Vox Sanguinis, 2020
Plasma provided by COVID‐19 convalescent patients may provide therapeutic relief as the number of COVID‐19 cases escalates steeply worldwide. Prior findings in various viral respiratory diseases including SARS‐CoV‐related pneumonia suggest that ...
P. Tiberghien, X. Lamballerie, P. Morel, P. Gallian, K. Lacombe, Y. Yazdanpanah   +5 more
semanticscholar   +1 more source

Addressing data quality issues to assess clinical and epidemiological risk factors for COVID-19 among documented cases in Liberia: a single-centre, retrospective, observational study

BMJ Public Health
Introduction Identification of risk factors for severe COVID-19 can help to inform case management in resource-constrained settings. We aimed to rigorously but retroactively address data issues to identify risk factors for COVID-19 morbidity and ...
Laura Skrip, JERRY BROWN, Antoinette H Wright, Wahdae-Mai Harmon-Gray, Heounohu Hessou, Mukhtar Adeiza   +5 more
doaj   +1 more source

Inclusion of Cephalexin in COVID-19 Treatment Combinations May Prevent Lung Involvement in Mild Infections: A Case Report with Pharmacological Genomics Perspective

Global Medical Genetics, 2021
Novel coronavirus disease 2019 (COVID-19) is caused by a nonsegmented positive sense RNA, enveloped RNA virus that belongs to the family of β-coronaviridae.
Amir Khodavirdipour
doaj   +1 more source

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab

Immunobiology, 2020
In COVID-19, acute respiratory distress syndrome (ARDS) and thrombotic events are frequent, life-threatening complications. Autopsies commonly show arterial thrombosis and severe endothelial damage. Endothelial damage, which can play an early and central
A. Rambaldi, G. Gritti, M. Mico', M. Frigeni, G. Borleri, Anna Salvi, F. Landi, C. Pavoni, A. Sonzogni, A. Gianatti, F. Binda, S. Fagiuoli, F. Di Marco, L. Lorini, G. Remuzzi, S. Whitaker, G. Demopulos   +16 more
semanticscholar   +1 more source